Abstract
Extracorporeal photopheresis (ECP) has been used for nearly 30 years in the treatment of cutaneous T-cell lymphoma. However, current clinical practice largely reserves ECP for patients with late-stage mycosis fungoides (MF) or Sézary syndrome or for those who are refractory to other therapies. We briefly describe a 48-year-old male who experienced long-term complete remission of his patch MF disease with ECP, and we suggest a role for ECP in the treatment of early-stage MF given evidence of its efficacy, safety, and tolerability.
Original language | English (US) |
---|---|
Article number | e12485 |
Journal | Dermatologic Therapy |
Volume | 30 |
Issue number | 3 |
DOIs | |
State | Published - May 1 2017 |
Keywords
- Mycosis fungoides
- Sézary syndrome
- early stage
- extracorporeal photopheresis
ASJC Scopus subject areas
- Dermatology